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Tinea incognito is a dermatophytosis with atypi-
cal clinical manifestation in the absence of the typical 
“ringworm” (1). The term tinea incognito was original-
ly used in 1968 by Ive and Marks in 14 patients with 
atypical dermatophytic infection caused by a previ-
ous steroid treatment (2) . Since then, several cases of 
tinea incognito have been described after topical ap-
plication of pimecrolimus and tacrolimus, although 
the use of corticosteroids continues to be the most 
common trigger of the disease (3). 
A 47-year-old woman presented at our Institute 
with a 3-month history of erythematous papules 
with rare pustules on the face. The patient reported 
a three-month application of topical corticosteroids 
and metronidazole cream with progressive exacerba-
tion of the eruption.
Physical examination revealed numerous papules 
and some pustules forming an erythematous plaque 
localized on the face (Fig.1). No pathologic signs were 
observed on the rest of the body and nails. The pa-
tient’s history was otherwise unremarkable.
Scrapings from the facial lesion, examined direct-
ly in 10% potassium hydroxide solution, showed the 
presence of dermatophyte hyphae.
Culture on Mycosel Agar (agar-dextrose + cyclo-
eximide + chloramphenicol) at 27 °C for three weeks 
yielded colonies with a powdery and granular sur-
face and yellowish reverses (Fig. 2). Microscopically, 
we observed round and pyriform microconidia, spiral 
hyphae and rare smooth-walled macroconidia. These 
findings confirmed the diagnosis of dermatophyte 
infection caused by Trichophyton mentagrophytes vr. 
mentagrophytes.
A diagnosis of rosacea-like tinea incognito was 
made and the patient started therapy with oral terbi-
nafine 250 mg/die for 4 weeks, with progressive and 
total resolution of the facial lesions.
Tinea faciei, a relatively uncommon dermatophyte 
infection, usually shows up as an erythematous, scaly 
patch with an annular edge, the size of which gradu-
ally increases. Clinical presentation of the condition 
is often atypical. The absence of classical features of 
ringworm, likely because of the complex anatomy of 
the face, makes the initial diagnosis difficult and of-
ten leads to misdiagnosis of tinea faciei (1). 
Figure 1. Papules and some pustules forming an ery-
thematous plaque on the face.
Figure 2. Macroscopic appearance of Trichophyton 
mentagrophytes colonies. 
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A broad range of skin diseases, like seborrheic 
dermatitis, cutaneous candidiasis, atopic dermatitis, 
contact dermatitis, granuloma annulare, systemic 
and discoid lupus erythematosus, rosacea, drug-in-
duced lupus, perioral dermatitis, pityriasis alba, pityri-
asis rosea, sarcoidosis, tuberculosis, psoriasis vulgaris, 
and polymorphic light eruption can mimic tinea facei 
(1-3).  
This can lead to misdiagnosis of the disease, con-
sequential use of steroids, and finally to worsening of 
the disease and onset of tinea incognito.
The pathogenesis of tinea incognito is presumably 
linked to a steroid-modified response of the host to 
fungal infection rather than to a direct pharmacologi-
cal effect on the mycete (3). Topical steroids suppress 
the local immune response and allow the fungus to 
grow easily. As a result, the fungal infection may take 
on a bizarre appearance.
The prevalence of dermatophytes responsible for 
the condition shows marked geographical variation 
(4,5). 
In Italy, Trichophyton rubrum, Trichophyton men-
tagrophytes, Epidermophyton floccosum, Microsporum 
canis, Microsporum gypseum, Trichophyton violaceum, 
and Trichophyton erinacei have been reported as the 
main etiologic agents (5). 
Tinea faciei responds to treatment with topical 
or⁄and oral antifungals. 
Patients with highly inflamed lesions, resistant, 
extensive and complicated disease, or those with 
multiple plaques may require oral antifungal therapy, 
as in our case.
Terbinafine, itraconazole, and fluconazole have 
been shown to be superior to griseofulvin because 
they concentrate at the level of the skin (4). 
The presented case highlights the importance of 
considering tinea on the differential diagnosis of all 
facial eruptions and the essential role of mycological 
examination to make a correct diagnosis and treat-
ment.
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